Myocardial protection by dilazep HC1, an antianginal drug and a potent calcium antagonist, against myocardial damage following acute ischemia and reperfusion was studied with respect to myocardial contractility in isolated blood-perfused canine left ventricular muscle. Myocardial function was expressed by percent recovery rate of maximal net developed tension.
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1) The coronary infusion of dilazep revealed significant myocardial protection during normothermic ischemic arrest of 45 min and reperfusion.
2) The intravenous administration of dilazep to the support dog and Young's infusion also showed significant myocardial protection during normothermic ischemic arrest of 45 min and reperfusion. Dilazep showed no persistent depression of myocardial contractility due to its calcium antagonistic effect during reperfusion.
3) The combination of intravenous administration of dilazep to the support dog, Young's infusion, and hypothermia showed significant myocardial protection during prolonged ischemia and reperfusion even in hypertrophied
ventricle. These results demonstrate that dilazep provides effective myocardial protection during ischemic arrest and reperfusion by preventing abnormal calcium accumulation in myocardial cells during reperfusion.
No persistent depression of myocardial contractility during reperfusion may support dilazep's clinical application as a myocardial protective agent in open-heart surgery. reperfusion injury that has been noticed in the field of myocarcial protection in cardiac surgery is that the swollen mitochondria obtained from ischemic myocardium contain deposits of calcium phosphate and amorphous matrix densities, and particularly, many of these changes become more intense when blood flow is restored.1),2) The mechanism of the uptake of calcium and matrix density has not been established. However, it appears to be related to a defect in cellular permeability or mitochondrial function.3), 4 Moreover, it is likely that the reperfusion injury may be a contributing factor in transient myocardial dysfunction.5) It is apparent that a series of potent calcium antagonists block only calcium influx without affecting simultaneous Na+ movement which is connected with the action potential. This electromechanical dissociation leads to diminished ATP consumption by the cardiac muscle, and to diminished contractile force of the myocardium. As a result, both CP and ATP levels in the heart muscle increase, resulting in a diminution of myocardial O2 demand by the heart.6)-8) Therefore, it is assumed that some potent calcium antagonists favorably reduce the myocardial damage of reperfusion injuries by blocking calcium influx and increasing ATP in the myocardium.
The present studies were designed to assess the myocardial protective effect against ischemic arrest of dilazep HC1,9) recognized as an antianginal drug and a potent calcium antagonist, by investigating myocardial contractility in isolated blood perfused canine left ventricular preparation. 
MATERIALS

DISCUSSION
The protective effects of topical cardiac cooling against myocardial damage during ischemic cardiac arrest in cardiac surgery advocated by Schumway and his associates12)-14) are already well recognized. Recently, various potassium-based cardioplegic solutions which were first advocated by Melrose15) and Young16) have been assessed experimentally with respect to myocardial protection and several of these cardioplegic solutions have been used clinically17)-27) with topical cardiac cooling or with perfusion cooling. Moreover, metabolic arrest with procaine, hypocalcemia, magnesium, fluoride, adrenochrome, and tetrodotoxin28) or metabolic myocardial protection with allopurinol29) and high-energy solutions30) for myocardial protection during ischemic myocardium have been investigated. On the other hand, it has been noted that reperfusion injuries may play an important role in the development of myocardial damage after ischemic arrest.1)-5) Recent studies have shown a rapid increase in intracellular calcium ion concentration associated with a reduction in mitochondrial metabolism.1)-3) Therefore, besides the protection against myocardial damage during ischemic arrest, the 
